PCSK9 and chronic obstructive pulmonary disease: Recent studies suggest that alterations in lipid metabolic pathways contribute to pathogenesis of lung diseases, including fibrosis and COPD, plasma PCSK9 level was associated only with secondary outcomes of fewer intensive care unit free and ventilator free days17.